Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller
  2. Migueles, Stephen A.; Chairez, Cheryl; Lin, Siying; Cavil, Noah; Rosenthal, Danielle M.; Pooran, Milad; Natarajan,Ven; Rupert,Adam; Dewar,Robin; Rehman, Tauseef; Sherman,Brad; Adelsberger,Joe; Leitman, Susan F.; Stroncek, David; Morse, Caryn G.; Connors, Mark; Lane, H. Clifford; Kovacs, Joseph A.
  3. JCI INSIGHT. 2019, SEP 19; 4(18):
  1. 2.   Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells
  2. He, S.; Wang, J. N.; Kato, K.; Xie, F.; Varambally, S.; Mineishi, S.; Kuick, R.; Mochizuki, K.; Liu, Y. N. A.; Nieves, E.; Mani, R. S.; Chinnaiyan, A. M.; Marquez, V. E.; Zhang, Y.
  3. Blood. 2012, Feb; 119(5): 1274-1282.
  1. 3.   Characterization and polymorphic analysis of 4.5 kb genomic full-length HLA-C in the Chinese Han population
  2. Xu, Y.; Deng, Z.; O'HUigin, C.; Wang, D.; Gao, S.; Zeng, J.; Yang, B.; Jin, S.; Zou, H.
  3. Tissue Antigens. 2011, Aug; 78(2): 102-114.
  1. 4.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 5.   Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
  2. Shusterman, S.; London, W. B.; Gillies, S. D.; Hank, J. A.; Voss, S. D.; Seeger, R. C.; Reynolds, C. P.; Kimball, J.; Albertini, M. R.; Wagner, B.; Gan, J.; Eickhoff, J.; DeSantes, K. B.; Cohn, S. L.; Hecht, T.; Gadbaw, B.; Reisfeld, R. A.; Maris, J. M.; Sondel, P. M.
  3. Journal of Clinical Oncology. 2010, Nov; 28(33): 4969-4975.
  1. 6.   Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34(+) cells
  2. Kim, Y. J.; Kim, Y. S.; Larochelle, A.; Renaud, G.; Wolfsberg, T. G.; Adler, R.; Donahue, R. E.; Hematti, P.; Hong, B. K.; Roayaei, J.; Akagi, K.; Riberdy, J. M.; Nienhuis, A. W.; Dunbar, C. E.; Persons, D. A.
  3. Blood. 2009 113(22): 5434-5443.
  1. 7.   Availability of activated CD4(+) T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys
  2. Klatt, N. R.; Villinger, F.; Bostik, P.; Gordon, S. N.; Pereira, L.; Engram, J. C.; Mayne, A.; Dunham, R. M.; Lawson, B.; Ratcliffe, S. J.; Sodora, D. L.; Else, J.; Reimann, K.; Staprans, S. I.; Haase, A. T.; Estes, J. D.; Silvestri, G.; Ansari, A. A.
  3. Journal of Clinical Investigation. 2008 118(6): 2039-2049.
  1. 8.   A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
  2. Mackall, C. L.; Rhee, E. H.; Read, E. J.; Khuu, H. M.; Leitman, S. F.; Bernstein, D.; Tesso, M.; Long, L. M.; Grindler, D.; Merino, M.; Kopp, W.; Tsokos, M.; Berzofsky, J. A.; Helman, L. J.
  3. Clinical Cancer Research. 2008 14(15): 4850-4858.
  1. 9.   An inducible and reversible mouse genetic rescue system
  2. Zeng, H. K.; Horie, K.; Madisen, L.; Pavlova, M. N.; Gragerova, G.; Rohde, A. D.; Schimpf, B. A.; Liang, Y. Q.; Ojala, E.; Kramer, F.; Roth, P.; Slobodskaya, O.; Dolka, I.; Southon, E. A.; Tessarollo, L.; Bornfeldt, K. E.; Gragerov, A.; Pavlakis, G.
  3. Plos Genetics. 2008 4(5): 1-13.
  1. 10.   Loss of naive cells accompanies memory CD4(+) T-cell depletion during long-term progression to AIDS in simian immunodeficiency virus-infected macaques
  2. Nishimura, Y.; Igarashi, T.; Buckler-White, A.; Buckler, C.; Imamichi, H.; Goeken, R. M.; Lee, W. R.; Lafont, B. A. P.; Byrum, R.; Lane, H. C.; Hirsch, V. M.; Martin, M. A.
  3. Journal of Virology. 2007, Jan; 81(2): 893-902.
  1. 11.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 12.   Membrane TNF confers protection to acute mycobacterial infection
  2. Fremond, C.; Allie, N.; Dambuza, I.; Grivennikov, S. I.; Yeremeev, V.; Quesniaux, V. F. J.; Jacobs, M.; Ryffel, B.
  3. Respiratory Research. 2005, NOV 14; 6(Art. No 136):
  1. 13.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 14.   Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation
  2. Petersen, S. L.; Sidorov, I. A.; Russell, C. A.; Dickmeiss, E.; Vindelov, L. L.
  3. Transplantation. 2005, SEP 15; 80(5): 573-581.
  1. 15.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 16.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 17.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 18.   An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
  2. Welniak, L. A.; Wang, Z.; Sun, K.; Kuziel, W.; Anver, M. R.; Blazar, B. R.; Murphy, W. J.
  3. Experimental Hematology. 2004 32(3): 318-324.
  1. 19.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 20.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 21.   Is thymus redundant after adulthood?
  2. Shanker, A.
  3. Immunology Letters. 2004 91(2-3): 79-86.
  1. 22.   Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration
  2. Dorshkind, K.; Welniak, L.; Gault, R. A.; Hixon, J.; Montecino-Rodriguez, E.; Horseman, N. D.; Gertner, J. M.; Murphy, W. J.
  3. Clinical Immunology. 2003 109(2): 197-202.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel